More News


  • 10-November-2017

    English

    OECD Health Statistics 2017

    OECD Health Statistics 2017 is the most comprehensive source of comparable statistics on health and health systems across OECD countries. All datasets have been updated on 10 November 2017, including the datasets for Pharmaceutical Market and Health Care Quality Indicators.

  • 10-November-2017

    English

    Healthier lifestyles and better health policies drive life expectancy gains

    Healthier lifestyles, higher incomes and better education have all contributed to boost life expectancy in recent decades. Better health care has also helped, according to a new OECD report.

    Related Documents
  • 6-November-2017

    English

    Healthy people, healthy planet

    This document, produced to inform the 2017 meeting of the G7 Ministers of Health, provides a broad overview of the main policy issues and some of the policy actions that G7 Health authorities can put in place to improve population health, while at the same time decreasing the human footprint on the environment.

    Related Documents
  • 25-October-2017

    English

    Public Health Reviews

    This new series of OECD Reviews of Public Health provide in-depth analysis and policy recommendations to strengthen priority areas of countries’ public health systems, highlighting best practice examples that allow learning from shared experiences, and the spreading of innovative approaches.

  • 10-October-2017

    English

    Mental Health Systems in OECD Countries

    Mental disorders represent a considerable disease burden, and have a significant impact on the lives of the OECD population, and account for considerable direct and indirect costs. This report argues that even in those OECD countries with a long history of deinstitutionalisation, there is still a long way to go to make community-based mental health care that achieves good outcomes for people with severe mental illness a reality.

  • 22-September-2017

    English

    The microbiome, diet and health: Towards a science and innovation agenda

    There is now strong evidence that microbiomes play an important role in human health, as there are clear linkages to many major non-communicable diseases. This report assesses the key policy challenges for innovation in the microbiome. It argues that if such a promising scientific field is to lead to innovative applications, policies on science and innovation must be improved in five areas.

    Related Documents
  • 19-July-2017

    English

    Health Update - The OECD Newsletter on Health

    Read about the release of Obesity Update 2017, our work with the G20 Summit and antimicrobial resistance (AMR), the latest about Universal Health Coverage with the OECD joining UHC2030, and the report on the Economics of Patient Safety (prepared for the 2nd Global Ministerial Summit on Patient Safety). And access our latest Health Working Papers.

    Related Documents
  • 6-July-2017

    English

    Universal Health Coverage

    Universal Health Coverage is about everyone having access to good quality health services without suffering financial hardship. Although most OECD countries offer all their citizens affordable access to a comprehensive package of health services, they face challenges in sustaining and enhancing such universal systems.

    Related Documents
  • 24-May-2017

    English

    Output-based hospital-specific Purchasing Power Parities

    Purchasing Power Parities (PPPs) are commonly used to convert national currencies to a common unit. The main novel feature in the 2017 report is the collection of comparable and output-based prices for hospital services that can then be applied to matching health accounts expenditure data so as to derive consistent price and volume comparisons of health and hospital goods and services consumed.

  • 18-May-2017

    English

    Antimicrobial Resistance

    Antimicrobial resistance is a growing health and economic threat requiring multipronged responses. The OECD provides a forum for discussion and provide countries with the evidence to implement effective and cost-effective policies to tackle AMR, promote effective use of antimicrobials and incentivise research and development in the antibiotic sector.

  • 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 > >>